RIDE Seminar Series

White text reading "RIDE Seminar Series"
composite of four images of different people taking part in veterinary activities

The CVM Research, Innovation, Discovery, and Education (RIDE) Seminar Series offers a platform for cutting-edge exploration and discussion in the field of veterinary biomedical research. The series will bring engaging experts from diverse disciplines to present their latest findings, methodologies, and innovations, fostering a dynamic exchange of ideas. The RIDE Seminars will serve as a catalyst for collaboration and intellectual growth, promoting advancements that contribute to the forefront of One Health biomedical knowledge and its applications in animal healthcare.

Upcoming Seminars

July 17, 12-1 p.m., AS/VM 135

Chand Khanna, DVM, PhD, DACVIM, DACVP, "A comparative and iterative approach to osteosarcoma metastasis biology and therapy"

The 2024 CVM Distinguished Alum Awardee will be presenting a seminar during the lunch hour at the RIDE Summit. A recording will be posted after the event. CVM students, staff, and faculty can RSVP for the Summit here by July 3.

Past seminars


June 12, 2024

Susan Arnold, DVM, "Breed-associated differentially-expressed genes in canine high-grade glioma: Will these findings have translational impact for human glioblastoma multiforme?"

Canine high grade glioma is an aggressive primary brain tumor that develops spontaneously in dogs. It shares many key features with human glioblastoma multiforme (GBM), the deadliest and most common glioma in people. A key feature of GBM malignancy is inter-patient tumor heterogeneity. Dog breeds have narrow genetic pools, which contributes to breed-associated heritability of various conditions. This presentation summarizes the key differences in expression patterns between glioma-bearing French bulldogs and other breeds, which may provide important information to optimize the canine model of GBM as a means to benefit both canine and human glioma patients. 

Stuart Lichtenberg, PhD, "Search and destroy: Prion identification and remediation"

The unabated spread of chronic wasting disease results in substantial prion deposition in the broader environment, leading to substantial risk to susceptible animals, as well as raising the specter of cross-species transmission via indirect routes. New research from Dr. Lichtenberg is underway to glean structural information about prions from ultra-sensitive amplification assays. In addition, Dr. Lichtenberg's research group is investigating new methods for prion decontamination and carcass disposal.

Expand all


Noelle Noyes, DVM, PhD - May 8, 2024
“How does pooling impact the observed microbiome diversity and composition of fecal samples collected from piglets?”

Steven Friedenberg, DVM, PhD - May 8, 2024
"Insights and challenges from a decade of studying autoimmune diseases in dogs"

Aniruddha Belsare, PhD - April 10, 2024
“Investigating complex host-pathogen systems using pragmatic agent-based models” 
Aniruddha Belsare, PhD (Auburn University)

Ferenc Toth, DVM, PhD & Bruce Walcheck, PhD - March 13, 2024
“A quest to develop a large animal models of developmental orthopaedic diseases”
Ferenc Toth, DVM, PhD
“Manipulating leukocytes and their receptors to kill cancer cells better”
Bruce Walcheck, PhD

“Research in an A.I. World: Balancing Innovation and Integrity” - February 27, 2024
Moderated by: Peter Larsen, assistant professor at CVM
Featured panelists:
Dr. Joseph Konstan, associate dean for research, UMN College of Sciences and Engineering
Dr. Gerard Cramer, associate professor at CVM; Manci Li, graduate student at CVM
Dr. Jonah Cullen, postdoctoral associate at CVM
Drew Swartz, graduate student at CVM AI program ChatGPT.